Characterization of erythrovirus B19 genomes isolated in liver tissues from patients with fulminant hepatitis and biliary atresia who underwent liver transplantation

International Journal of Medical Sciences

Volumn 4, Issue 2, 2007, Pages 105-109

  Abe, Kenji ^a   Kiuchi, Tetsuya ^b   Tanaka, Koichi ^c,d   Edamoto, Yoshihiro ^e   Aiba, Naoto ^f   Sata, Tetsutaro ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

^d INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^e NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^f Aiba Clinic   (Japan)

Author keywords

Biliary atresia; Erythrovirus B19; Erythrovirus B19 genome; Fulminant hepatitis; Liver transplantation

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BILE DUCT ATRESIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS; HUMAN; HUMAN TISSUE; INFANT; LIVER TRANSPLANTATION; MALE; NUCLEOTIDE SEQUENCE; PARVOVIRUS; PATHOGENESIS; VIRUS GENOME;

EID: 34147129641     PISSN: None     EISSN: 14491907     Source Type: Journal    
DOI: 10.7150/ijms.4.105     Document Type: Article

References (25)

1. Langnas AN, Markin RS, Cattral MS, et al. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology 1995; 22: 1661-5
2. Sokal EM, Melchior M, Cornu C, et al. Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children. Lancet 1998; 352: 1739-41
3. Yoto Y, Kudoh T, Haseyama K, et al. Human parvovirus B19 infection associated with acute hepatitis. Lancet 1996; 347: 868-9
4. Abe K, Inami T, Ishikawa K, et al. TT virus infection in non-human primates and characterization of the viral genome: Identification of simian TT virus isolates. J Virol. 2000; 74: 1549-53.
5. Romano L, Fabris P, Tanzi E, et al. GBV-C/hepatitis G virus in acute nonA-E hepatitis and in acute hepatitis of defined aetiology in Italy. J Med Virol. 2000; 61: 59-64
6. Alter MJ, Gallagher M, Morris TT, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team. N Engl J Med. 1997; 336: 741-6
7. Chu CM, Lin SM, Hsieh SY, et al. Etiology of sporadic acute viral hepatitis in Taiwan: the role of hepatitis C virus, hepatitis E virus and GB virus-C/hepatitis G virus in an endemic area of hepatitis A and B. J Med Virol. 1999; 58: 154-9
8. Sato S, Suzuki K, Takikawa Y, et al. Japanese National Study Group of Fulminant Hepatitis. Clinical epidemiology of fulminant hepatitis in Japan before the substantial introduction of liver transplantation: an analysis of 1309 cases in a 15-year national survey. Hepatol Res. 2004; 30: 155-61
9. Balistreri WF, Grand R, Hoofnagle JH, et al. Biliary atresia: current concepts and research directions. Summary of a symposium. Hepatology 1996; 6: 1682-92
10. Sokol RJ, Mack C. Etiopathogenesis of biliary atresia. Semin Liver Dis. 2001; 21:517- 24.
11. Bobo L, Ojeh C, Chiu D, et al. Lack of evidence for rotavirus by polymerase chain reaction/enzyme immunoassay of hepatobiliary samples from children with biliary atresia. Pediatr Res. 1997; 41: 229-34
12. Riepenhoff-Talty M, Gouvea V, Evans MJ, et al. Detection of group C rotavirus in infants with extrahepatic biliary atresia. J Infect Dis. 1996; 174: 8-15
13. Fischler B, Ehrnst A, Forsgren M, et al. The viral association of neonatal cholestasis in Sweden: a possible link between cytomegalovirus infection and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr. 1998; 27: 57-64
14. Tarr PI, Haas JE, Christie DL. Biliary atresia, cytomegalovirus, and age at referral. Pediatrics 1996; 97: 828-31
15. Karetnyi YV, Beck PR, Markin RS, et al. Human parvovirus B19 infection in acute fulminant liver failure. Arch Virol. 1999; 144: 1713-24
16. Wong S, Young NS, Brown KE. Prevalence of parvovirus B19 in liver tissue: no association with fulminant hepatitis or hepatitis-associated aplastic anemia. J Infect Dis. 2003; 187: 1581-6
17. Cattral MS, Langnas AN, Markin RS, et al. Aplastic anemia after liver transplantation for fulminant liver failure. Hepatology 1994; 20: 813-8
18. Ozawa K, Kurtzman G, Young N. Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro. Blood 1987; 70: 384-91
19. Lee WM, Brown KE, Young NS, et al. No evidence for parvovirus B19 or hepatitis E virus as a cause of acute liver failure. Dig Dis Sci. 2006; 51:1712-5
20. Eis-Hubinger AM, Reber U, Abdul-Nour T, Glatzel U, Lauschke H, Putz U. Evidence for persistence of parvovirus B19 DNA in livers of adults. J Med Virol. 2001; 65: 395-401
21. Ozawa K, Ayub J, Kajigaya S, et al. The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells. J Virol. 1988; 62: 2884-9
22. Doerig C, Hirt B, Antonietti JP, et al. Nonstructural protein of parvoviruses B19 and minute virus of mice controls transcription. J Virol. 1990; 64: 387-96
23. Moffatt S, Tanaka N, Tada K, et al. A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J Virol. 1996; 70: 8485-91
24. Poole BD, Karetnyi YV, Naides SJ. Parvovirus B19-induced apoptosis of hepatocytes. J Virol. 2004; 78: 7775-83
25. Poole BD, Zhou J, Grote A, Schiffenbauer A, Naides SJ. Apoptosis of liver-derived cells induced by parvovirus B19 nonstructural protein. J Virol. 2006; 80: 4114-21